Kathryn Bigelow’s A House of Dynamite is built on a great idea, rippling with urgency and tension. Out of nowhere, an ICBM is ...

Epigram's River Korkmaz and Lily Scogings attended the opening night of the 30th Encounters Film Festival and were treated to ...

Are you ready for a high-voltage thriller? As you'll see, the concept starts strong, promising one of those films that will ...

Recursion Pharmaceuticals shows high cash burn, limited efficacy data, and unproven platform validation. Check out why RXRX ...

Okay, I had Recursion on when they were 9, 10. They did an equity offering. The stock got clobbered. It’s been down.

We recently published 10 Big Names Beating Wall Street at its Own Game. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Monday. Recursion Pharmaceuticals soared by 13.99 ...

Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down ...